Literature DB >> 23886684

Synthesis of quaternary α-amino acid-based arginase inhibitors via the Ugi reaction.

Adam Golebiowski1, Darren Whitehouse, R Paul Beckett, Michael Van Zandt, Min Koo Ji, Todd R Ryder, Erik Jagdmann, Monica Andreoli, Yung Lee, Ryan Sheeler, Bruce Conway, Jacek Olczak, Marzena Mazur, Wojciech Czestkowski, Wieslawa Piotrowska, Alexandra Cousido-Siah, Francesc X Ruiz, Andre Mitschler, Alberto Podjarny, Hagen Schroeter.   

Abstract

The Ugi reaction has been successfully applied to the synthesis of novel arginase inhibitors. In an effort to decrease conformational flexibility of the previously reported series of 2-amino-6-boronohexanoic acid (ABH) analogs 1, we designed and synthesized a series of compounds, 2, in which a piperidine ring is linked directly to a quaternary amino acid center. Further improvement of in vitro activity was achieved by adding two carbon bridge in the piperidine ring, that is, tropane analogs 11. These improvements in activity are rationalized by X-ray crystallography analysis, which show that the tropane ring nitrogen atom moves into direct contact with Asp202 (arginase II numbering). The synthetic routes described here enabled the design of novel arginase inhibitors with improved potency and markedly different physico-chemical properties compared to ABH. Compound 11c represents the most in vitro active arginase inhibitor reported to date.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ABH; Arginase inhibitor; Boronic acid; Metalloenzyme; Ugi reaction

Mesh:

Substances:

Year:  2013        PMID: 23886684     DOI: 10.1016/j.bmcl.2013.06.092

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  15 in total

1.  Crystal structures of Leishmania mexicana arginase complexed with α,α-disubstituted boronic amino-acid inhibitors.

Authors:  Yang Hai; David W Christianson
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-03-16       Impact factor: 1.056

Review 2.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

Review 3.  Pharmacokinetics and Pharmacodynamics of Promising Arginase Inhibitors.

Authors:  Khaled S Abdelkawy; Kelsey Lack; Fawzy Elbarbry
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

Review 4.  The versatility of boron in biological target engagement.

Authors:  Diego B Diaz; Andrei K Yudin
Journal:  Nat Chem       Date:  2017-07-25       Impact factor: 24.427

5.  Synthesis, evaluation and molecular modelling of piceatannol analogues as arginase inhibitors.

Authors:  J Muller; B Cardey; A Zedet; C Desingle; M Grzybowski; P Pomper; S Foley; D Harakat; C Ramseyer; C Girard; M Pudlo
Journal:  RSC Med Chem       Date:  2020-04-17

6.  Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer Immunotherapy.

Authors:  Matthew J Mitcheltree; Derun Li; Abdelghani Achab; Adam Beard; Kalyan Chakravarthy; Mangeng Cheng; Hyelim Cho; Padmanabhan Eangoor; Peter Fan; Symon Gathiaka; Hai-Young Kim; Charles A Lesburg; Thomas W Lyons; Theodore A Martinot; J Richard Miller; Spencer McMinn; Jennifer O'Neil; Anandan Palani; Rachel L Palte; Josep Saurí; David L Sloman; Hongjun Zhang; Jared N Cumming; Christian Fischer
Journal:  ACS Med Chem Lett       Date:  2020-03-23       Impact factor: 4.345

7.  Discovery and Pharmacokinetics of Sulfamides and Guanidines as Potent Human Arginase 1 Inhibitors.

Authors:  Roman Blaszczyk; Joanna Brzezinska; Barbara Dymek; Paulina S Stanczak; Marcin Mazurkiewicz; Jacek Olczak; Julita Nowicka; Karolina Dzwonek; Agnieszka Zagozdzon; Jakub Golab; Adam Golebiowski
Journal:  ACS Med Chem Lett       Date:  2020-03-13       Impact factor: 4.345

8.  Deregulation of arginase induces bone complications in high-fat/high-sucrose diet diabetic mouse model.

Authors:  Anil Bhatta; Rajnikumar Sangani; Ravindra Kolhe; Haroldo A Toque; Michael Cain; Abby Wong; Nicole Howie; Rahul Shinde; Mohammed Elsalanty; Lin Yao; Norman Chutkan; Monty Hunter; Ruth B Caldwell; Carlos Isales; R William Caldwell; Sadanand Fulzele
Journal:  Mol Cell Endocrinol       Date:  2015-12-17       Impact factor: 4.102

9.  Crystal structure of Schistosoma mansoni arginase, a potential drug target for the treatment of schistosomiasis.

Authors:  Yang Hai; Jennifer E Edwards; Michael C Van Zandt; Karl F Hoffmann; David W Christianson
Journal:  Biochemistry       Date:  2014-07-09       Impact factor: 3.162

10.  Cinnamide Derivatives as Mammalian Arginase Inhibitors: Synthesis, Biological Evaluation and Molecular Docking.

Authors:  Thanh-Nhat Pham; Simon Bordage; Marc Pudlo; Céline Demougeot; Khac-Minh Thai; Corine Girard-Thernier
Journal:  Int J Mol Sci       Date:  2016-09-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.